ReP USP - Resultado da busca

Artigo de periodico
Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors (2017)
Buzatto, I. P. C.; Ribeiro-Silva, Alfredo; Andrade, Jurandyr Moreira de; Carrara, Helio Humberto Angotti; Tiezzi, Daniel Guimarães
Fonte: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS, QUIMIOTERAPIA ADJUVANTE, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUZATTO, I. P. C. et al. Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors. Brazilian Journal of Medical and Biological Research, v. 50, n. 2, 2017Tradução . . Disponível em: https://doi.org/10.1590/1414-431x20165674. Acesso em: 20 jul. 2024.
APA
Buzatto, I. P. C., Ribeiro-Silva, A., Andrade, J. M. de, Carrara, H. H. A., & Tiezzi, D. G. (2017). Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors. Brazilian Journal of Medical and Biological Research, 50( 2). doi:10.1590/1414-431x20165674
NLM
Buzatto IPC, Ribeiro-Silva A, Andrade JM de, Carrara HHA, Tiezzi DG. Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors [Internet]. Brazilian Journal of Medical and Biological Research. 2017 ; 50( 2):[citado 2024 jul. 20 ] Available from: https://doi.org/10.1590/1414-431x20165674
Vancouver
Buzatto IPC, Ribeiro-Silva A, Andrade JM de, Carrara HHA, Tiezzi DG. Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors [Internet]. Brazilian Journal of Medical and Biological Research. 2017 ; 50( 2):[citado 2024 jul. 20 ] Available from: https://doi.org/10.1590/1414-431x20165674
Artigo de periodico
Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up (2016)
Andrade, Jurandyr Moreira de; Brito, Luiz G. O.; Moisés, Elaine Christine Dantas; Amorim, Andréa C.; Rapatoni, Liane; Carrara, Helio Humberto Angotti; Tiezzi, Daniel Guimarães
Fonte: Anti-Cancer Drugs. Unidade: FMRP
Assuntos: ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS, QUIMIOTERAPIA ADJUVANTE, COMPLICAÇÕES NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Jurandyr Moreira de et al. Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up. Anti-Cancer Drugs, v. 27, n. 4, p. 369-372, 2016Tradução . . Disponível em: https://doi.org/10.1097/CAD.0000000000000344. Acesso em: 20 jul. 2024.
APA
Andrade, J. M. de, Brito, L. G. O., Moisés, E. C. D., Amorim, A. C., Rapatoni, L., Carrara, H. H. A., & Tiezzi, D. G. (2016). Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up. Anti-Cancer Drugs, 27( 4), 369-372. doi:10.1097/CAD.0000000000000344
NLM
Andrade JM de, Brito LGO, Moisés ECD, Amorim AC, Rapatoni L, Carrara HHA, Tiezzi DG. Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up [Internet]. Anti-Cancer Drugs. 2016 ; 27( 4): 369-372.[citado 2024 jul. 20 ] Available from: https://doi.org/10.1097/CAD.0000000000000344
Vancouver
Andrade JM de, Brito LGO, Moisés ECD, Amorim AC, Rapatoni L, Carrara HHA, Tiezzi DG. Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up [Internet]. Anti-Cancer Drugs. 2016 ; 27( 4): 369-372.[citado 2024 jul. 20 ] Available from: https://doi.org/10.1097/CAD.0000000000000344
Artigo de periodico
Breast conserving surgery after neoadjuvant therapy for large primary breast cancer (2008)
Tiezzi, Daniel Guimarães; Andrade, Jurandyr Moreira de; Marana, Heitor Ricardo Cosiski; Zola, Fábio Eduardo; Peria, Fernanda Maris
Fonte: Eurpean Journal of Surgical Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS MAMÁRIAS (CIRURGIA), QUIMIOTERAPIA ADJUVANTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TIEZZI, Daniel Guimarães et al. Breast conserving surgery after neoadjuvant therapy for large primary breast cancer. Eurpean Journal of Surgical Oncology, v. 34, n. 8, p. 863-867, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejso.2008.01.015. Acesso em: 20 jul. 2024.
APA
Tiezzi, D. G., Andrade, J. M. de, Marana, H. R. C., Zola, F. E., & Peria, F. M. (2008). Breast conserving surgery after neoadjuvant therapy for large primary breast cancer. Eurpean Journal of Surgical Oncology, 34( 8), 863-867. doi:10.1016/j.ejso.2008.01.015
NLM
Tiezzi DG, Andrade JM de, Marana HRC, Zola FE, Peria FM. Breast conserving surgery after neoadjuvant therapy for large primary breast cancer [Internet]. Eurpean Journal of Surgical Oncology. 2008 ; 34( 8): 863-867.[citado 2024 jul. 20 ] Available from: https://doi.org/10.1016/j.ejso.2008.01.015
Vancouver
Tiezzi DG, Andrade JM de, Marana HRC, Zola FE, Peria FM. Breast conserving surgery after neoadjuvant therapy for large primary breast cancer [Internet]. Eurpean Journal of Surgical Oncology. 2008 ; 34( 8): 863-867.[citado 2024 jul. 20 ] Available from: https://doi.org/10.1016/j.ejso.2008.01.015
Trabalho de evento-resumo
Induction of apoptosis predicts response to neoadjuvant chemotherapy in locally advanced breast cancer (2005)
Tiezzi, Daniel Guimarães; Andrade, Jurandir Moreira de; Reis, Francisco José Cândido dos; Marana, Heitor Ricardo Cosiski; Bighetti, Sérgio; Ribeiro-Silva, Alfredo; Pereira, Antônio Plácido
Fonte: Resumos. Nome do evento: Congresso Brasileiro de Patologia. Unidade: FMRP
Assuntos: APOPTOSE, QUIMIOTERAPIA ADJUVANTE, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TIEZZI, Daniel Guimarães et al. Induction of apoptosis predicts response to neoadjuvant chemotherapy in locally advanced breast cancer. 2005, Anais.. Natal: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2005. . Acesso em: 20 jul. 2024.
APA
Tiezzi, D. G., Andrade, J. M. de, Reis, F. J. C. dos, Marana, H. R. C., Bighetti, S., Ribeiro-Silva, A., & Pereira, A. P. (2005). Induction of apoptosis predicts response to neoadjuvant chemotherapy in locally advanced breast cancer. In Resumos. Natal: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Tiezzi DG, Andrade JM de, Reis FJC dos, Marana HRC, Bighetti S, Ribeiro-Silva A, Pereira AP. Induction of apoptosis predicts response to neoadjuvant chemotherapy in locally advanced breast cancer. Resumos. 2005 ;[citado 2024 jul. 20 ]
Vancouver
Tiezzi DG, Andrade JM de, Reis FJC dos, Marana HRC, Bighetti S, Ribeiro-Silva A, Pereira AP. Induction of apoptosis predicts response to neoadjuvant chemotherapy in locally advanced breast cancer. Resumos. 2005 ;[citado 2024 jul. 20 ]

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Indexado em